What You Should Know:
PhaseV a pioneer in causal machine learning (ML) technology that optimizes clinical trial design and analysis, announced today that it has raised $15 million in funding, led by Viola Ventures and Exor Ventures, including participation from LionBird and a group of prominent angel investors.A recent Deloitte study estimates the average cost of developing a single new drug at $2.3 billion in 2022, with an average 7.1 year deployment time. Moreover, the vast
Read More
SocialClimb, IncludeHealth Partner to Revolutionize Orthopedic Patient Experience
What You Should Know:
SocialClimb, a leader in the patient acquisition industry, and IncludeHealth, a leading digital musculoskeletal (MSK) solution provider, today announced a partnership that promises to redefine the orthopedic patient marketing experience.Through this collaboration, SocialClimb's orthopedic clientele will have access to a state-of-the-art digital self-assessment tool provided by IncludeHealth, that boosts online conversions and draws new patients to
Read More
Rymedi Raises $9M for Blockchain-Secured Data Platform
What You Should Know:
Rymedi, a healthcare data exchange platform with advanced blockchain security, has announced a Series A totaling $9 million with plans to expand the reach of their platform.The round was co-led by RW3 Ventures and White Star Capital with participation from Blockchange Ventures, Avalanche’s Blizzard Fund, and strategic angel investors from the healthcare industry. Rymedi, which serves over 1 million patients in over 1,200
Read More
Harmonic Health Launches Dementia Care Delivery Solution
What You Should Know:
Harmonic Health, announced the launch of its comprehensive, evidence-based, dementia care model that bridges gaps in care by bringing together advanced technology and an expert care team to partner with physician, to provide comprehensive care management and support patients and caregivers facing neurodegenerative diseases. Harmonic launched its initial services with Stoney Batter Family Medicine, a trusted family medical practice serving over 24,000 patients
Read More
Weave Launches AI-Driven Voicemail Transcriptions for Healthcare Providers
What You Should Know:
Weave, a leading all-in-one experience platform for small and medium-sized healthcare practices, today announces the addition of AI-driven voicemail transcriptions to its Phones offering.Now available to Weave’s 27,000+ customers, Voicemail Transcription will enhance Weave Phones by automatically transcribing voicemails from patients, allowing for efficient, visible, and private reading experiences of voicemails. With this update, users will now see the voicemail
Read More
3 in 4 Patients Don’t Trust AI in Healthcare Setting
What You Should Know:
Carta Healthcare®, a company whose mission is to improve patient care by harnessing the value of clinical data, today announced the results of a survey measuring American perception and trust of artificial intelligence (AI) in healthcare.Propeller Insights conducted an online survey of 1,027 U.S. consumers between August 18 and August 29, 2023.
Evolving Public Perception of the Role of AI in Healthcare – Key Insights
The survey finds that on average,
Read More
Penn Medicine Taps Flatiron Health for Advanced Cancer Care
What You Should Know:
Flatiron Health today announced a new agreement to bring Flatiron Assist™ advanced cancer care insights to oncology care clinicians at Penn Medicine’s Abramson Cancer Center (ACC).The collaboration between Flatiron Health and Penn Medicine will focus on further enabling clinicians at ACC to determine and promote site-preferred pathways and open clinical trials at the point of care alongside the NCCN Clinical Practice Guidelines in Oncology (NCCN
Read More
Cedars-Sinai Uses AI to Identify People With Abnormal Heart Rhythms
What You Should Know:
Investigators from the Smidt Heart Institute at Cedars-Sinai found that an artificial intelligence (AI) algorithm can detect an abnormal heart rhythm in people not yet showing symptoms.The algorithm, which identified hidden signals in common medical diagnostic testing, may help doctors better prevent strokes and other cardiovascular complications in people with atrial fibrillation-the most common type of heart rhythm disorder.
AI-Driven Algorithm to Detect
Read More
Pangea, FibroFighters Partner to Advance Rare Liver Cancer Treatment
What You Should Know:
Pangea Biomed, the startup behind the innovative treatment response predictor, ENLIGHT, today announced its partnership with patient-centric advocacy organization FibroFighters to advance treatment for fibrolamellar carcinoma (FLC) patients.Fibrolamellar carcinoma (FLC) is a rare liver cancer that typically presents in young adolescents and young adults at a median age of 22 who have no history of liver disease. There is no clear standard of care for the disease, and in
Read More
Nucleus RadioPharma Secures $56M to Expand Radiopharmaceutical Treatments for Cancer Patients
What You Should Know:
Today, Nucleus RadioPharma the world’s first fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals has announced an oversubscribed $56 million Series A funding round led by Eclipse and GE HealthCare with participation from Echo Global, Fox Chase Cancer Center, Granger Management, Mayo Clinic, Mercy Health, and University of Missouri.With this round of funding,
Read More
